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RE: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a 
susceptibility-weighted imaging study  
 
Sir—We read with great interest the article by Oztoprak et al. regarding the 
morphology of what they describe as “atypical multiple sclerosis lesions” [1]. Their 
paper addresses an important clinical issue and provides insights into the formation of 
such lesions.  
 
The article raises a number of points that are integral to the ongoing debate about the 
value of intralesional veins as a diagnostic feature to distinguish multiple sclerosis 
(MS) from other white matter lesions. Although we understand this was not the 
primary aim of the paper, it certainly provides information relevant to this issue. 
 
At our centre we have been using a co-registered fluid attenuated inversion recovery 
(FLAIR) and T2* technique (FLAIR*, [2]) at 3 T, and post-contrast medium 
administration to assess venous anatomy in MS plaques, as we find that white matter 
lesions are more conspicuous and the venous anatomy better defined, and this saves 
the reader from having to “match up” each lesion on two separate sequences. We 
find there are particular problems with the definition of lesions, which the authors 
have defined as “patchy”, as these may contain multiple traversing veins; however, it 
is difficult to determine whether these veins are associated with the lesion or 
incidentally passing through it, as the authors note.  
 
This brings up the issue of a consensus definition of a “central vein”, which has 
remained elusive despite multiple studies on the subject. The central vein has been 
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defined as “considered to be present if its hypointensity appeared at the centre of the 
surrounding hyperintense lesion in at least 2 of 3 orthogonal planes” [3] which 
remains the most complete definition, but does not eliminate incidental crossing veins 
or account for large lesions. The authors description of the morphology of the lesion 
with respect to the vein, i.e. clearly formed along it, may be more useful, however 
remains difficult to objectively define. 
 
The issue of objectivity in assessment of these lesions is also an important aspect in 
these investigations. Even the identification of white matter lesions shows 
interobserver variation. Thus, a consensus on morphology may be difficult to reach. 
The authors mention in their methods that lesions found to be “atypical by one 
radiologist and typical by the other were excluded, along with lesions determined as 
uncertain”. The boundaries between “typical” and “atypical” lesions cannot be clearly 
defined if an “uncertain” category exists. Similarly, lesions “in contact with one 
another or having uncertain borders” were excluded. It would be interesting to know 
what proportion of lesions had to be excluded on these grounds, as these are often 
the lesions that lead to diagnostic challenges. 
 
It may also be that assessment of these “atypical” lesions is unnecessary in clinical 
practice. For example, Mistry et al. developed a set of criteria based on 
“morphologically characteristic lesions” of MS, which reduces the assessment time as 
only six lesions are required for the analysis [4]. Their approach correctly categorised 
20 patients as having either MS or microangiopathic white matter lesions. These 
morphological characteristics relate to what the authors describe as “typical” MS 
lesions, for example, Dawson’s finger lesions and ovoid perivenous lesions. 
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We agree with the conclusions that more comparative studies are required to 
determine the usefulness of lesion morphology in differentiating the underlying cause, 
and suggest that this should lead to consensus definitions of useful morphological 
characteristics to allow widespread clinical use.  
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